https://www.nature.com/articles/s41467-022-34400-8
0
0
65 words
0
Comments
Updated vaccines based on Omicron subvariants have started to being rolled out. Analysis of antibody response in individuals with two or three vaccine doses suggests that BA.2 breakthrough infection barely increases cross-neutralization capacity against BA.4/…
You are the first to view
Create an account or login to join the discussion